EasiBioArmour. Development and production of a surgical gown with enhanced antiviral and antibacterial properties which is bio-based and biodegradable

易生物装甲。

• 批准号: 78731
• 金额: $ 23.74万
• 依托单位: LYNAM PHARMA LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=78731
• 关键词: EasiBioArmour.; Development; production; surgical; gown

The spread of infectious diseases continues to grow worldwide, with increased risks of zoonotic based pathogens transferring to humans. The recent global pandemic of nCOVID-19 has led to supply chain challenges for personal protective equipment (PPE) in particular surgical gowns leading to NHS and other healthcare staff having insufficient protective equipment which is comfortable, provides an effective antiviral barrier, and at an affordable cost to the NHS and other healthcare institutions.The majority of gowns used in hospitals and clinic settings are designed to be discarded after single use. These are produced using petrochemical based synthetic fibres (eg. polypropylene, polyester and polyethylene). This led to the idea of producing a surgical gown which has enhanced antiviral/antibacterial properties and is produced using bio-based and biodegradable sustainable material.Lynam Pharma Limited is working with the Nonwovens Innovation and Research Institute to develop a surgical gown which has enhanced antiviral and antibacterial properties using bio-based and biodegradable sustainable materials.

传染病在世界范围内继续蔓延，人畜共患病原体转移给人类的风险增加。最近的nCOVID-19全球大流行导致了个人防护设备（PPE）的供应链挑战，特别是手术衣，导致NHS和其他医护人员没有足够的防护设备，这些设备舒适，提供有效的抗病毒屏障，并且对于NHS和其他医疗保健机构来说，成本是可以承受的。医院和诊所使用的大多数长袍都是为了在一次性使用。这些是使用石化合成纤维（例如，聚丙烯、聚酯和聚乙烯）。因此，Lynam Pharma有限公司与非织造布创新研究院合作，开发一种使用生物基和可生物降解的可持续材料，增强抗病毒/抗菌性能的手术衣。